Multiple Independent Molecular Signals Converge to Validate GRI-0621 as a Potential Disease-Modifying Therapy LA JOLLA, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or ...

Korro Bio (NASDAQ:KRRO) used its Analyst Day to outline the rationale and development plans for KRRO-121, an RNA-editing ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function LA JOLLA, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) ...

MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory ...

Aviva Bio is advancing AVA-291 (d3-T) as a differentiated testosterone in a broad development program addressing multiple ...

COGNIZIN (R) CITICOLINE NAMED "FUNCTIONAL INGREDIENT TO WATCH IN 2026" BY MINTEL & BLACK SWAN DATA, SHOWCASING ITS EXPLOSIVE GROWTH IN THE BRAIN HEALTH CATEGORY Independent recognition underscores ...

Zach Galifianakis, Sarah Goldberg, Simon Helberg and more co-star in the new AMC series "The Audacity" from Jonathan Glatzer ...

Flerie AB's (publ) portfolio company KAHR Bio announced a median overall survival of 17.5 months in its Phase II trial with DSP107, combined with the anti-PD-L1 immunotherapy atezolizumab, in patients ...

D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has ...

Some are frightened, others are dehydrated, most are burned. In order to provide aid to the furry friends and other animals ...

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs ...

The 2,5-FDCA segment is projected to command 54.2% of the total market revenue by the end of 2025. This dominance is attributed to its critical role as a monomer for bio-polyesters. Its adoption is ...